July 15, 2011 -- Bristol-Myers Squibb expects China to become its second or third largest market within a decade. That’s a big jump from eighth place currently and a projected sixth next year. To get this task accomplished, BMS will increase its R&D staff in Shanghai, and it plans to increase its number of collaborations with domestic China pharmas. More details....
Stock Symbol: (NYSE: BMY)
